Savvy Updates 8/1/22: Dexcom G7 DELAYED, Immune System May Not Be Cause of T1D, Abvance Therapeutics Insulin/Glucagon
Dexcom to resubmit G7 glucose monitor software for FDA review, pushing back US launch was posted by Conor Hale for FierceBioTech.Com, 29 July 2022. Diabetes tracker developer Dexcom is pushing back the timeline for a U.S. launch of the latest generation of its...
Savvy Updates, 7/25/22: GSK-126 Restores Beta Cells, SpaceX Grows Stem Cells, Trigger Finger/Carpal Tunnel Gene Variant, UnitedHealthcare $0 Insulin CoPay Only Will Affect Few, POGO BG Meter UPDATE
Experimental drug may help restore insulin-producing cells was written by Clarissa Brincat for MedicalNewsToday.com, 22 July 2022. In a recent study, the human epigenetics team at Monash University in Melbourne, Australia, found that the investigational drug GSK-126...
Savvy Travel Tips: Traveling with Diabetes from TCOYD
TCOYD: Taking Care of Your Diabetes with Drs. Steve Edelman and Jeremy Pettus. Learn and giggle some too! Learn some travel tips from these type 1 diabetes jet setters before setting out on your next worldwide adventure, or even just for your next staycation....
Savvy Updates, 7/18/22: Power of YOUR VOICES to the US FDA, Timely Access to Care Act, About Chocolate
Diabetes Patients Flood FDA with Comments on Cybersecurity for Medical Devices, as reported by Mariam Baksh for NextGov.com, 8 July 2022. The Food and Drug Administration received more than a thousand comments—mainly from diabetes patients and their family...
Savvy Updates, 7/11/22: Vertex Resumes Testing, US Senate Dems Move to Lower Drug Prices, Potatoes Better with Vinegar, Sugar Cravings Reduce by New Gum
Vertex, continuing its rebound, cleared to resume testing of diabetes cell therapy was written by Ben Fidler for BioPharmaDive.com, 6 July 2022. The Food and Drug Administration has cleared Vertex Pharmaceuticals to resume a study evaluating an...
Savvy Updates, 7/5/22: Call for Advocacy: FDA re CGM Access to Data & Cybersecurity, How Immune Cells Learn, POGO BG Meter, Sleep Quality & T1D
The ENTIRE Diabetes Community needs you to take action. The US FDA held a webinar on Cybersecurity in Medical Devices in June 2022, asking for feedback and comments, accepted through 7 July 2022. Time is of the ESSENCE! At issue: Unlimited,...
Savvy Updates 6/27/22: 4/5 of US PWDs in Debt for Medical Costs/Insulin, Hydration Affects BG Levels
4 Out Of 5 Americans With Diabetes Went Into Debt To Pay For Insulin was contributed by Deb Gordon for Forbes.com, 20 June 2022. According to a new study, released in earliy June from CharityRx, 79% of U.S. adults who have diabetes or care for someone who does...
Savvy Extras, 6/21/22: From DiabetesMine D-Data Exchange 2022
DiabetesMine D-Data is an extraordinary semi-annual event that showcases significant and unique topics in diabetes technology and management, hosted by founder/T1D Amy Tenderich. This year’s virtual was, as always, informative, educational, and exciting to...
Savvy Updates 6/20/22: Study to Regenerate Beta Cells, Senseonics Eversense E3 180-day CGM Gets CE Mark, Piezoelectric Button to Control T1D, Insulin & Weight Gain, Lager Beer Improves Gut Health, Best Time to Exercise Differs by Sex, Recession Impact on Medical Device Growth
New potential diabetes treatment regenerates insulin-producing cells was written by Michael Irving for NewAtlas.com, 13 June 2022. An emerging way to treat diabetes is to repair or replace the cells in the body that naturally produce insulin. Swedish researchers have...
More Diabetes Blogs